June 29, 2017

Board Of Directors

MangoGen’s Board of Directors

satya_prakashProfessor Satya Prakash PhD

President and Co-Founder

Dr. Prakash is a professor of biomedical engineering at McGill University, QC, Canada. Dr. Prakash leads a research team dedicated to the advancement and development of bioengineered delivery systems, including targeted controlled-release, targeted drug systems and cell delivery mechanisms. The goal is to design biotherapeutics that are capable of targeting specific cell types, organs or tissues to treat specific medical conditions. Dr. Prakash has had over 150 scientific publications, and 60 approved/pending patent applications. In 2003, Dr. Prakash co-founded Micropharma, a microbiome company based in Montreal, Canada. As Director of Micropharma, Prakash has taken scientific discovery through and into the commercial world. Dr. Prakash, is a co-inventor of MangoGen’s patented technology.

PlestedC. Paul Plested D.Phil (Oxford)

CEO and Co-Founder

Dr. Plested obtained his PhD in neuroscience from University of Oxford. After several post-doctorates, Dr. Plested turned to consulting and business development, where he established his own successful communication business venture, Noviatrica, where he acted as a consultant to GSK, Mirati, HIT Global, Tactus Scientific and McGill University. Working full-time as CEO of MangoGen, he has successfully developed the company from its original conception to where it is today. Dr. Plested has a broad medical knowledge that includes cardiovascular disease, neuroscience, human parturition, oncology, vaccinology, and parasitology. Dr. Plested has had 16 scientific publications and a patent application.

IMG_1194Dr. Dominique Shum-Tim., MD., MSc., FRCSC

Chief Medical Officer and Co-Founder

Dr. Shum-Tim is a professor at the department of surgery at McGill University and a practicing cardiothoracic surgeon in the at the McGill University Health Centre (MUHC), Montreal. Dr. Shum-Tim was trained at McGill University and Harvard Medical School, Children’s Hospital, Boston. He specializes in both pediatric and adult cardiac surgery, and maintains an active research interest in cerebral protection during cardiac surgery, tissue engineering and stem cell myocardial regeneration. Dr. Shum-Tim is a co-inventor of MangoGen’s patented technology.

Mr. Fengyou Lu

Senior Vice President of Scientific Affairs (Asia)

Lu joined MangoGen’s Board of Directors in September 2017.